Warning: The NCBI web site requires JavaScript to function. more...
Short-term and long-term success of electrical cardioversion in atrial fibrillation in managed care system.
Kuppahally SS, Foster E, Shoor S, Steimle AE.
Int Arch Med. 2009 Dec 12;2:39.
Related citations
Factors predicting success rate and recurrence of atrial fibrillation after first electrical cardioversion in patients with persistent atrial fibrillation.
Frick M, Frykman V, Jensen-Urstad M, Ostergren J, Rosenqvist M.
Clin Cardiol. 2001 Mar;24(3):238-44.
Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
Pisters R, Nieuwlaat R, Prins MH, Le Heuzey JY, Maggioni AP, Camm AJ, Crijns HJ; for the Euro Heart Survey Investigators.
Europace. 2012 Jan 5. [Epub ahead of print]
Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation.
Van Noord T, Crijns HJ, van den Berg MP, Van Veldhuisen DJ, Van Gelder IC.
BMC Cardiovasc Disord. 2005 Jan 24;5(1):3.
Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.
Heart. 2002 May;87(5):443-8.
Does advanced age affect the immediate and long-term results of direct-current external cardioversion of atrial fibrillation?
Fumagalli S, Boncinelli L, Bondi E, Caleri V, Gatto S, Di Bari M, Baldereschi G, Valoti P, Masotti G, Marchionni N.
J Am Geriatr Soc. 2002 Jul;50(7):1192-7.
Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G, Diemberger I, Biffi M, Domenichini G, Martignani C, Valzania C, Branzi A.
Int J Clin Pract. 2007 May;61(5):748-56.
Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrillation.
Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, Coin D, Di Donna P, Giustetto C.
Circ Arrhythm Electrophysiol. 2008 Oct;1(4):269-75.
n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.
Europace. 2011 Feb;13(2):174-81. Epub 2010 Nov 8.
Does flecainide regain its antiarrhythmic activity after electrical cardioversion of persistent atrial fibrillation?
Tieleman RG, Van Gelder IC, Bosker HA, Kingma T, Wilde AA, Kirchhof CJ, Bennekers JH, Bracke FA, Veeger NJ, Haaksma J, Allessie MA, Crijns HJ.
Heart Rhythm. 2005 Mar;2(3):223-30.
Electrical cardioversion for atrial fibrillation: outcomes in "real-life" clinical practice.
Berry C, Stewart S, Payne EM, McArthur JD, McMurray JJ.
Int J Cardiol. 2001 Nov;81(1):29-35.
Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
Hemels ME, Van Noord T, Crijns HJ, Van Veldhuisen DJ, Veeger NJ, Bosker HA, Wiesfeld AC, Van den Berg MP, Ranchor AV, Van Gelder IC.
J Am Coll Cardiol. 2006 Sep 5;48(5):1001-9. Epub 2006 Aug 17.
Clinical value of left atrial appendage flow for prediction of long-term sinus rhythm maintenance in patients with nonvalvular atrial fibrillation.
Antonielli E, Pizzuti A, Pálinkás A, Tanga M, Gruber N, Michelassi C, Varga A, Bonzano A, Gandolfo N, Halmai L, Bassignana A, Imran MB, Delnevo F, Csanády M, Picano E.
J Am Coll Cardiol. 2002 May 1;39(9):1443-9.
[Clinical role of flow velocity of left atrial auricle for prediction of short and long term success of cardioversion in patients with non-valvular atrial fibrillation].
Pálinkás A, Varga A, Nyúzó B, Gruber N, Forster T, Nemes A, Horváth T, Fogas J, Boda K, Sepp R, Hógye M, Vass A, Csanády M.
Orv Hetil. 2002 Sep 1;143(35):2035-41. Hungarian.
Electrical cardioversion for persistent or chronic atrial fibrillation: outcome and clinical factors predicting short and long term success rate.
Blich M, Edoute Y.
Int J Cardiol. 2006 Mar 8;107(3):389-94.
[Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
Kosior D, Szulc M, Zawadzka M, Pierścińska M, Stawicki S, Rabczenko D, Torbicki A, Opolski G.
Pol Arch Med Wewn. 2002 Dec;108(6):1151-60. Polish.
Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
Loricchio ML, Cianfrocca C, Pasceri V, Bianconi L, Auriti A, Calo L, Lamberti F, Castro A, Pandozi C, Palamara A, Santini M.
Am J Cardiol. 2007 May 15;99(10):1421-4. Epub 2007 Apr 5.
Clinical predictors and time course of arrhythmia recurrence in patients with early reinitiation of atrial fibrillation after successful internal cardioversion.
Tse HF, Lau CP.
Pacing Clin Electrophysiol. 2003 Sep;26(9):1809-14.
Time to cardioversion of recurrent atrial arrhythmias after catheter ablation of atrial fibrillation and long-term clinical outcome.
Baman TS, Gupta SK, Billakanty SR, Ilg KJ, Good E, Crawford T, Jongnarangsin K, Ebinger M, Pelosi F Jr, Bogun F, Chugh A, Morady F, Oral H.
J Cardiovasc Electrophysiol. 2009 Dec;20(12):1321-5. Epub .
VERDICT: the Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.
Van Noord T, Van Gelder IC, Tieleman RG, Bosker HA, Tuinenburg AE, Volkers C, Veeger NJ, Crijns HJ.
J Cardiovasc Electrophysiol. 2001 Jul;12(7):766-9.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on